All News
Advertisement
Advertisement
This article discusses the supply chain benefits of pharma companies distributing from South Florida.
This op-ed discusses the varying skills that business leaders should look at in scientists when thinking about talent for the lab and the executive suite.
Advertisement
Leela Barham reviews the Institute for Clinical Effectiveness Review's announced pilot program, which allow manufacturers to scrutinize executable versions of draft cost-effectiveness models.
Click the title above to open the Pharmaceutical Executive April 2018 issue in an interactive PDF format.
Advertisement
In terms of important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs, writes Bagrat Lalayan.
Click the title above to open the Pharmaceutical Executive March 2018 issue in an interactive PDF format.
Drawing parallels from the world of football coaching in evaluating and grooming future C-suite pharma leaders-call it the quest to see "what right looks like?"
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5
